España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Marex Group
MRX
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$19.22
0.0100
0.05%
At Close: -
$19.21
-0.0100
-0.05%
After Hours: Jul 2, 4:00 PM EDT
15 minutes delayed
Get Report
Watch
Marex Group (MRX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Marex Group (NASDAQ:MRX) Stock
Marex Group Stock (NASDAQ: MRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, June 05, 2024
BNY Mellon Boosts Investment Solutions via Bundle Services
Zacks
Tuesday, May 28, 2024
Stifel And Marex Announce Prime Brokerage Ref...
Benzinga Newsdesk
Monday, May 20, 2024
Analysts Launch Coverage On Marex Group Stock: What You Need To Know
Vaishali Prayag
UBS Initiates Coverage On Marex Group with Bu...
Benzinga Newsdesk
Citigroup Initiates Coverage On Marex Group w...
Benzinga Newsdesk
Barclays Initiates Coverage On Marex Group wi...
Benzinga Newsdesk
Jefferies Initiates Coverage On Marex Group w...
Benzinga Newsdesk
Keefe, Bruyette & Woods Initiates Coverage On...
Benzinga Newsdesk
Piper Sandler Initiates Coverage On Marex Gro...
Benzinga Newsdesk
Goldman Sachs Initiates Coverage On Marex Gro...
Benzinga Newsdesk
Thursday, May 16, 2024
Marex Group Fiscal 2023 Revenue $1.245B Up fr...
Benzinga Newsdesk
Thursday, April 25, 2024
Marex Group Shares Open For Trade At $19.50/S...
Benzinga Newsdesk
Marex Group IPO Indicating $19.50/Share On 1,...
Benzinga Newsdesk
Marex Group IPO Indicating $20/Share On 652,1...
Benzinga Newsdesk
Wednesday, April 24, 2024
Marex Group Plc IPOs Tomorrow, Here's What You Need To Know
Benzinga Insights
Sunday, April 21, 2024
A Look At Upcoming IPOs For The Week
Benzinga Insights
Monday, April 15, 2024
Marex Group plc Announces Launch Of Initial P...
Benzinga Newsdesk
Wednesday, December 05, 2012
Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
Benzinga
Medicis Pharmaceutical Spikes Higher on 8-K Filing Regarding Dismissed Lawsuit
Benzinga
Medicis Pharmaceutical Spikes Higher
Benzinga
Friday, November 16, 2012
Valeant Pharmaceuticals Receives FTC Clearance For Medicis Acquisition
Benzinga
Valeant Pharma Receives FTC Clearance for Med...
Benzinga
Wednesday, November 14, 2012
Eric Mindich's Eton Park Capital 13F Shows Ne...
Benzinga
Friday, November 09, 2012
Medicis Pharmaceutical Spokesperson Has No Comment Other than What is Mentioned in 10-Q
Benzinga
Medicis Pharmaceutical Spikes Lower
Benzinga
Monday, October 08, 2012
Revance Therapeutics Regains All Worldwide Rights to Its Botulinum Toxin Products; Will Make Upfront Payment of $7M, Up to Added $18M Payments; Medicis Will Keep Equity Stake in Revance
Benzinga
Wednesday, October 03, 2012
UPDATE: Morgan Stanley Reiterates Equal-Weight Rating, Raises PT on Medicis Pharmaceutical
Benzinga
Morgan Stanley Maintains Medicis Pharmaceutic...
Benzinga
Tuesday, September 25, 2012
Medicis Gets Notice of Zyclara Allowance, Cit...
Benzinga
Monday, September 24, 2012
Susquehanna Downgrades Medicis Pharmaceutical...
Benzinga
Downgrades Medicis Pharmaceutical from Posit...
Benzinga
Thursday, September 13, 2012
Valeant Pharmaceuticals Announces Management Change
Benzinga
Wednesday, September 05, 2012
Barclays Maintains Medicis Pharmaceutical at ...
Benzinga
UPDATE: Stifel Nicolaus Downgrades Medicis Pharmaceutical to Hold
Benzinga
UPDATE: Goldman Sachs Downgrades Medicis Pharmaceutical to Neutral, Raises PT
Benzinga
Stifel Nicolaus Downgrades Medicis Pharmaceut...
Benzinga
Goldman Sachs Downgrades Medicis Pharmaceutic...
Benzinga
Tuesday, September 04, 2012
Benzinga's M&A Chatter for Tuesday September 4, 2012
Benzinga
Valeant Soars on Medicis Buyout
Benzinga
Piper Jaffray Downgrades Medicis Pharmaceutic...
Benzinga
Canaccord Maintains Medicis Pharmaceutical at...
Benzinga
Benzinga's Top Pre-Market Gainers
Benzinga
Benzinga Market Primer, Tuesday September 4
Benzinga
Medicis Pharmaceutical Bid 36% Higher Pre-Mar...
Benzinga
Cantor Fitzgerald Maintains Medicis Pharmaceu...
Benzinga
Credit Suisse Upgrades Medicis Pharmaceutical...
Benzinga
US Stock Futures Up; ISM Manufacturing Data In Focus
Benzinga
Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Highest ROA
Benzinga
Stocks To Watch For September 4, 2012
Benzinga
Monday, September 03, 2012
Valeant Pharmaceuticals Agrees To Acquire Medicis Pharmaceutical for $44.00 Per Share In Cash
Benzinga
Show More